Semaglutide primarily targets the mechanisms involved in glucose regulation, primarily affecting insulin and related hormones
In pharmacological research, higher dosing does not necessarily improve outcomes, particularly with high-potency peptide therapies
A comprehensive 2024 review in Diabetes Care confirmed that gastrointestinal symptoms remain among the most common limitations of GLP-1 therapy and the primary reason patients discontinue treatment
Harnessing the chemical composition and anti-oxidant, anti-enzymatic, and anti-cancer activities of two Corydalis species ( C
It is directly involved in development of cardiometabolic diseases, ischemic coronary heart disease peripheral arterial disease, heart failure, and arterial hypertension, producing global morbidity and mortality
This has resulted in drug substances or products that presenting different impurity profiles compared to the original drug